S137 Benralizumab is effective at reducing airway inflammation in severe asthma patients following non-response to mepolizumab associated with persistent sputum eosinophilia G Tavernier, P Aspin,LJ Holmes, L Elsey,R Niven,CT Pantin,D Allen,SJ FowlerThorax（2021）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
